{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:51:08Z","timestamp":1788389468730,"version":"build-2803163510"},"reference-count":142,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Catholic Medical Center Research Foundation","award":["52020B000100029"],"award-info":[{"award-number":["52020B000100029"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Peritoneal metastasis (PM) is one of the most frequent metastasis patterns of gastric cancer (GC), and the prognosis of patients with PM is very dismal. According to Paget\u2019s theory, disseminated free cancer cells are seeded and survive in the abdominal cavity, adhere to the peritoneum, invade the subperitoneal tissue, and proliferate through angiogenesis. In these sequential processes, several key molecules are involved. From a therapeutic point of view, immunotherapy with chemotherapy combination has become the standard of care for advanced GC. Several clinical trials of newer immunotherapy agents are ongoing. Understanding of the molecular process of PM and the potential rationale of immunotherapy for PM treatment is necessary. Beyond understanding of the molecular aspect of PM, many studies have been conducted on the modality of treatment of PM. Notably, intraperitoneal approaches, including chemotherapy or immunotherapy, have been conducted, because systemic treatment of PM has limitations. In this study, we reviewed the molecular mechanisms and immunologic aspects of PM, and intraperitoneal approaches under investigation for treating PM.<\/jats:p>","DOI":"10.3390\/biomedicines10061376","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T10:25:12Z","timestamp":1654856712000},"page":"1376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Molecular Mechanisms and Potential Rationale of Immunotherapy in Peritoneal Metastasis of Advanced Gastric Cancer"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7278-2174","authenticated-orcid":false,"given":"Donghoon","family":"Kang","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","article-title":"Recurrence following curative resection for gastric carcinoma","volume":"87","author":"Yoo","year":"2000","journal-title":"J. Br. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs","volume":"128","author":"Langley","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_5","first-page":"4234","article-title":"Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer","volume":"6","author":"Yonemura","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","article-title":"Tumor metastasis: Molecular insights and evolving paradigms","volume":"147","author":"Valastyan","year":"2011","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/path.4871","article-title":"Molecular insights into tumour metastasis: Tracing the dominant events","volume":"241","author":"Jin","year":"2017","journal-title":"J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4251\/wjgo.v2.i1.12","article-title":"Pathophysiology and biology of peritoneal carcinomatosis","volume":"2","author":"Kusamura","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.yexcr.2005.11.007","article-title":"E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts","volume":"312","author":"Kuphal","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yexcr.2017.04.006","article-title":"A central role for cadherin signaling in cancer","volume":"358","author":"Kourtidis","year":"2017","journal-title":"Exp. Cell Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ncb2909","article-title":"\u03b1-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-\u03baB signalling","volume":"16","author":"Piao","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1038\/s41388-018-0304-2","article-title":"E-cadherin in contact inhibition and cancer","volume":"37","author":"Mendonsa","year":"2018","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: Regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.ejca.2007.05.013","article-title":"Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer","volume":"43","author":"Kubben","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/gut.39.3.444","article-title":"Matrix metalloproteinase-7 expression in gastric carcinoma","volume":"39","author":"Honda","year":"1996","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/bjs.4868","article-title":"Clinical significance of mucin phenotype, \u03b2-catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma","volume":"92","author":"Aihara","year":"2005","journal-title":"J. Br. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10120-013-0302-6","article-title":"Clinicopathological significance of MMP-7, laminin \u03b32 and EGFR expression at the invasive front of gastric carcinoma","volume":"17","author":"Sentani","year":"2014","journal-title":"Gastric Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/PL00011698","article-title":"Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer","volume":"3","author":"Yonemura","year":"2000","journal-title":"Gastric Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2147\/DDDT.S75429","article-title":"The clinicopathological significance of CDH1 in gastric cancer: A meta-analysis and systematic review","volume":"9","author":"Zeng","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1002\/cncr.27565","article-title":"Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor\/extracellular signal-regulated kinase\/integrin beta-1-binding protein 1 pathway","volume":"118","author":"Cheng","year":"2012","journal-title":"Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2217\/fon.13.114","article-title":"Potential role of Anxa1 in cancer","volume":"9","author":"Guo","year":"2013","journal-title":"Future Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.3748\/wjg.v22.i30.6829","article-title":"Molecular mechanisms of peritoneal dissemination in gastric cancer","volume":"22","author":"Kanda","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.gene.2018.05.060","article-title":"NRAGE confers poor prognosis and promotes proliferation, invasion, and chemoresistance in gastric cancer","volume":"668","author":"Jiang","year":"2018","journal-title":"Gene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1111\/jcmm.16366","article-title":"ARL4C might serve as a prognostic factor and a novel therapeutic target for gastric cancer: Bioinformatics analyses and biological experiments","volume":"25","author":"Xie","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1245\/s10434-017-6292-6","article-title":"Identification of ARL4C as a peritoneal dissemination-associated gene and its clinical significance in gastric cancer","volume":"25","author":"Hu","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1002\/stem.1816","article-title":"Peritoneal milky spots serve as a hypoxic niche and favor gastric cancer stem\/progenitor cell peritoneal dissemination through hypoxia-inducible factor 1\u03b1","volume":"32","author":"Miao","year":"2014","journal-title":"Stem Cells"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1007\/s10620-020-06819-w","article-title":"HIF1A-AS2 Promotes the Proliferation and Metastasis of Gastric Cancer Cells Through miR-429\/PD-L1 Axis","volume":"66","author":"Mu","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1002\/jcb.28337","article-title":"HIF1A-AS2 predicts poor prognosis and regulates cell migration and invasion in triple-negative breast cancer","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7314\/APJCP.2014.15.1.17","article-title":"Roles of PTEN (Phosphatase and Tensin Homolog) in gastric cancer development and progression","volume":"15","author":"Xu","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_31","first-page":"1439","article-title":"MicroRNAs and the PTEN\/PI3K\/Akt pathway in gastric cancer","volume":"41","author":"Hu","year":"2019","journal-title":"Oncol. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cellsig.2014.01.025","article-title":"PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression","volume":"26","author":"Zhang","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.3892\/ijo.2014.2678","article-title":"Significance of AKT in gastric cancer","volume":"45","author":"Sasaki","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.21170","article-title":"Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer","volume":"117","author":"Oki","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_35","first-page":"4387","article-title":"Targeting AKT protein kinase in gastric cancer","volume":"31","author":"Almhanna","year":"2011","journal-title":"Anticancer. Res."},{"key":"ref_36","first-page":"1155","article-title":"The role of the CXCR4\/CXCL12 axis and its clinical implications in gastric cancer","volume":"27","author":"Lee","year":"2012","journal-title":"Histol. Histopathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-05-3393","article-title":"Role of the CXCL12\/CXCR4 axis in peritoneal carcinomatosis of gastric cancer","volume":"66","author":"Yasumoto","year":"2006","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/ijc.29864","article-title":"CXCL12\/CXCR4 activation by cancer-associated fibroblasts promotes integrin \u03b21 clustering and invasiveness in gastric cancer","volume":"138","author":"Izumi","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"152576","DOI":"10.1016\/j.prp.2019.152576","article-title":"Over expression of amphiregulin promoted malignant progression in gastric cancer","volume":"215","author":"Jiang","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1158\/1078-0432.CCR-10-2475","article-title":"The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer","volume":"17","author":"Yasumoto","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"76684","DOI":"10.18632\/oncotarget.12436","article-title":"Abnormal amphiregulin expression correlates with gastric cancer prognosis","volume":"7","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_42","first-page":"37","article-title":"Expression of LOX and MMP-2 in gastric cancer tissue and the effects of LOX and MMP-2 on tumor invasion and metastasis","volume":"33","author":"Ma","year":"2011","journal-title":"Zhonghua Zhong Liu Za Zhi [Chin. J. Oncol.]"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10120-015-0510-3","article-title":"Lysyl oxidase is associated with the epithelial\u2013mesenchymal transition of gastric cancer cells in hypoxia","volume":"19","author":"Kasashima","year":"2016","journal-title":"Gastric Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.7150\/jca.33223","article-title":"LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells","volume":"10","author":"Zhao","year":"2019","journal-title":"J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3892\/or_00000897","article-title":"Expression of angiopoietin-like 4 in human gastric cancer: ANGPTL4 promotes venous invasion","volume":"24","author":"Nakayama","year":"2010","journal-title":"Oncol. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"11127","DOI":"10.1038\/s41598-017-11769-x","article-title":"Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines","volume":"7","author":"Baba","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3892\/ol.2015.4011","article-title":"Regulation and clinical significance of the hypoxia-induced expression of ANGPTL4 in gastric cancer","volume":"11","author":"Kubo","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.7150\/thno.46001","article-title":"Nuclear MYH9-induced CTNNB1 transcription, targeted by staurosporin, promotes gastric cancer cell anoikis resistance and metastasis","volume":"10","author":"Ye","year":"2020","journal-title":"Theranostics"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/s41388-021-01988-y","article-title":"Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C\/EBP\u03b2-mediated PDGFB autocrine and paracrine signaling","volume":"40","author":"Du","year":"2021","journal-title":"Oncogene"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s00109-016-1447-7","article-title":"C\/EBP\u03b2 regulates homeostatic and oncogenic gastric cell proliferation","volume":"94","author":"Regalo","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3892\/ijo.2012.1490","article-title":"The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer","volume":"41","author":"Tsukada","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_52","first-page":"325","article-title":"Transforming growth factor \u03b21 produced in autocrine\/paracrine manner affects the morphology and function of mesothelial cells and promotes peritoneal carcinomatosis","volume":"26","author":"Na","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"ref_53","first-page":"373","article-title":"TGF-\u03b21 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis","volume":"29","author":"Lv","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.18632\/oncotarget.6977","article-title":"Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"key":"ref_55","first-page":"205","article-title":"Inhibition of peritoneal dissemination in human gastric cancer by MMP-7-specific antisense oligonucleotide","volume":"20","author":"Yonemura","year":"2001","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.1007\/s13277-014-2383-1","article-title":"RETRACTED ARTICLE: Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13","volume":"35","author":"Ye","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10120-014-0400-0","article-title":"Connective tissue growth factor inhibits gastric cancer peritoneal metastasis by blocking integrin \u03b13\u03b21-dependent adhesion","volume":"18","author":"Chen","year":"2015","journal-title":"Gastric Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1476-4598-10-122","article-title":"Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination","volume":"10","author":"Jiang","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-4598-13-100","article-title":"Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK\/Paxillin pathway","volume":"13","author":"Du","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1158\/0008-5472.CAN-04-0321","article-title":"Adhesion of gastric carcinoma cells to peritoneum mediated by \u03b13\u03b21 integrin (VLA-3)","volume":"64","author":"Takatsuki","year":"2004","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/bjc.1996.556","article-title":"Role of alpha 2 beta 1-and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma","volume":"74","author":"Nishimura","year":"1996","journal-title":"Br. J. Cancer"},{"key":"ref_62","first-page":"3849","article-title":"Up-regulation of hypoxia-inducible factor-1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer","volume":"26","author":"Yoshikawa","year":"2006","journal-title":"Anticancer. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10147-005-0508-7","article-title":"Role of VEGF-C and VEGF-D in lymphangiogenesis in gastric cancer","volume":"10","author":"Yonemura","year":"2005","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/cgt.2015.19","article-title":"MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer","volume":"22","author":"Jiang","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ccell.2017.07.001","article-title":"Intravascular survival and extravasation of tumor cells","volume":"32","author":"Strilic","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.canlet.2008.05.029","article-title":"Anoikis resistance and tumor metastasis","volume":"272","author":"Simpson","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrc3789","article-title":"Cancer cell survival during detachment from the ECM: Multiple barriers to tumour progression","volume":"14","author":"Buchheit","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_69","first-page":"6991","article-title":"Mechanisms of peritoneal dissemination in gastric cancer","volume":"14","author":"Sun","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhou, Q., Wang, H., Zhuo, W., Ding, Y., Lu, J., Wu, G., Xu, N., and Teng, L. (2020). Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers. Cancers, 12.","DOI":"10.3390\/cancers12082236"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.20517\/2394-4722.2018.08","article-title":"Molecular mechanism of peritoneal dissemination in gastric cancer","volume":"4","author":"Hu","year":"2018","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_72","first-page":"349","article-title":"A possible role of cytokines in the formation of peritoneal dissemination","volume":"11","author":"Yonemura","year":"1997","journal-title":"Int. J. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1756-9966-29-139","article-title":"Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis","volume":"29","author":"Lv","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_74","first-page":"1236","article-title":"Morphogenesis of peritoneal metastasis in human gastric cancer","volume":"41","author":"Kiyasu","year":"1981","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3892\/ijo.2012.1720","article-title":"Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties","volume":"42","author":"Liu","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","article-title":"Molecular basis of metastasis","volume":"359","author":"Chiang","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_77","first-page":"5422","article-title":"Bone morphogenetic protein and activin membrane-bound inhibitor overexpression inhibits gastric tumor cell invasion via the transforming growth factor-\u03b2\/epithelial-mesenchymal transition signaling pathway","volume":"15","author":"Yuan","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2017.04.002","article-title":"ASPP2 suppresses invasion and TGF-\u03b21-induced epithelial\u2013mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer","volume":"398","author":"Gen","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.bjc.6605561","article-title":"Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells","volume":"102","author":"Shinto","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8831466","DOI":"10.1155\/2020\/8831466","article-title":"Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer","volume":"2020","author":"Zhang","year":"2020","journal-title":"Dis. Markers"},{"key":"ref_81","first-page":"535","article-title":"Correlation between GDF15, MMP7 and gastric cancer and its prognosis","volume":"21","author":"Lu","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/cas.12330","article-title":"MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis","volume":"105","author":"Sakamoto","year":"2014","journal-title":"Cancer Sci."},{"key":"ref_83","first-page":"687","article-title":"Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice","volume":"53","author":"Hagiwara","year":"1993","journal-title":"Cancer Res."},{"key":"ref_84","first-page":"90","article-title":"Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity","volume":"26","author":"Shimotsuma","year":"1993","journal-title":"Lymphology"},{"key":"ref_85","first-page":"11","article-title":"The natural history of free cancer cells in the peritoneal cavity","volume":"169","author":"Yonemura","year":"2007","journal-title":"Recent Results Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Yonemura, Y., Ishibashi, H., Mizumoto, A., Tukiyama, G., Liu, Y., Wakama, S., Sako, S., Takao, N., Kitai, T., and Katayama, K. (2022). The Development of Peritoneal Metastasis from Gastric Cancer and Rationale of Treatment According to the Mechanism. J. Clin. Med., 11.","DOI":"10.3390\/jcm11020458"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.bbrc.2013.08.073","article-title":"Milky spot macrophages remodeled by gastric cancer cells promote peritoneal mesothelial cell injury","volume":"439","author":"Liu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12967-014-0267-1","article-title":"The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots","volume":"12","author":"Cao","year":"2014","journal-title":"J. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3892\/ijo.2013.2068","article-title":"HIF-1\u03b1 is a crucial factor in the development of peritoneal dissemination via natural metastatic routes in scirrhous gastric cancer","volume":"43","author":"Miyake","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1158\/1078-0432.CCR-14-1071","article-title":"Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer","volume":"20","author":"Javle","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1248\/yakushi.127.1533","article-title":"Immunotherapy against peritoneal dissemination by immunostimulatory CpG DNA","volume":"127","author":"Kuramoto","year":"2007","journal-title":"Yakugaku Zasshi"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/21645515.2015.1009814","article-title":"Clinically feasible approaches to potentiating cancer cell-based immunotherapies","volume":"11","author":"Seledtsov","year":"2015","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12935-021-02089-2","article-title":"New insights into M1\/M2 macrophages: Key modulators in cancer progression","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s12276-020-00538-y","article-title":"Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer","volume":"52","author":"Eum","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.7150\/jca.31787","article-title":"Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis","volume":"10","author":"Song","year":"2019","journal-title":"J. Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10120-017-0760-3","article-title":"Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma","volume":"21","author":"Harada","year":"2018","journal-title":"Gastric Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Ito, A., Kagawa, S., Sakamoto, S., Kuwada, K., Kajioka, H., Yoshimoto, M., Kikuchi, S., Kuroda, S., Yoshida, R., and Tazawa, H. (2021). Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07816-6"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fimmu.2017.00293","article-title":"Role of Distinct Natural Killer Cell Subsets in Anticancer Response","volume":"8","author":"Stabile","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3389\/fimmu.2018.03095","article-title":"Therapeutic Potential of Natural Killer Cells in Gastric Cancer","volume":"9","author":"Du","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1158\/1078-0432.CCR-0393-03","article-title":"ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma","volume":"10","author":"Tanaka","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8629","DOI":"10.1074\/jbc.270.15.8629","article-title":"Activation of natural killer cell migration by leukocyte integrin-binding peptide from intracellular adhesion molecule-2 (ICAM-2)","volume":"270","author":"Somersalo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/cmi.2011.40","article-title":"Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines","volume":"9","author":"Li","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.7150\/ijbs.64630","article-title":"Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer","volume":"17","author":"Cao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: Current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Qian, S., Villarejo-Campos, P., and Garc\u00eda-Olmo, D. (2021). The Role of CAR-T Cells in Peritoneal Carcinomatosis from Gastric Cancer: Rationale, Experimental Work, and Clinical Applications. J. Clin. Med., 10.","DOI":"10.3390\/jcm10215050"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"S1040","DOI":"10.1016\/j.annonc.2021.08.1481","article-title":"1372O CLDN 18.2-targeted CAR-T cell therapy in patients with cancers of the digestive system","volume":"32","author":"Qi","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/cgt.2016.14","article-title":"Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery","volume":"23","author":"Katz","year":"2016","journal-title":"Cancer Gene Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.3389\/fimmu.2018.02268","article-title":"Effective Targeting of TAG72(+) Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells","volume":"9","author":"Murad","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"13545","DOI":"10.18632\/oncotarget.14592","article-title":"Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosis","volume":"8","author":"Ang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.intimp.2019.05.009","article-title":"Recent advances in the study of regulatory T cells in gastric cancer","volume":"73","author":"Liu","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_112","first-page":"5384","article-title":"Accumulation and suppressive function of regulatory T cells in malignant ascites: Reducing their suppressive function using arsenic trioxide in vitro","volume":"15","author":"Hu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients with First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","article-title":"Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): A randomised, multicentre, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Kang","year":"2022","journal-title":"Lancet Oncol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/annonc\/mdy540","article-title":"Safety and efficacy of nivolumab in combination with S-1\/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric\/gastroesophageal junction cancer: Interim results of a randomized, phase II trial (ATTRACTION-4)","volume":"30","author":"Boku","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10120-018-00909-5","article-title":"Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: Results from the phase II nonrandomized KEYNOTE-059 study","volume":"22","author":"Bang","year":"2019","journal-title":"Gastric Cancer"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(17)31827-5","article-title":"Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"390","author":"Kang","year":"2017","journal-title":"Lancet"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.2217\/fon-2021-0176","article-title":"KEYNOTE-859: A Phase III study of pembrolizumab plus chemotherapy in gastric\/gastroesophageal junction adenocarcinoma","volume":"17","author":"Tabernero","year":"2021","journal-title":"Future Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","article-title":"Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","article-title":"Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine","volume":"357","author":"Sakuramoto","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","article-title":"Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): A phase 3 open-label, randomised controlled trial","volume":"379","author":"Bang","year":"2012","journal-title":"Lancet"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000493493","article-title":"Hyperthermic Intraperitoneal Chemotherapy\u2014Fading Perspective in the Light of Modern Systemic Chemotherapy?","volume":"34","author":"Garg","year":"2018","journal-title":"Visc. Med."},{"key":"ref_125","first-page":"1","article-title":"Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer","volume":"62","author":"Dedrick","year":"1978","journal-title":"Cancer Treat. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11605-016-3336-3","article-title":"Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?","volume":"21","author":"Chan","year":"2017","journal-title":"J. Gastrointest. Surg."},{"key":"ref_127","first-page":"1691","article-title":"Effectiveness of intraperitoneal chemotherapy using new-aged drugs for the peritoneal dissemination of gastric cancer","volume":"32","author":"Fushida","year":"2005","journal-title":"Gan Kagaku Ryoho"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","article-title":"Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients with Gastric Cancer with Peritoneal Metastasis: PHOENIX-GC Trial","volume":"36","author":"Ishigami","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejso.2007.12.003","article-title":"Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience","volume":"34","author":"Scaringi","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch. Surg."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive Surgery with or without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"794","DOI":"10.21147\/j.issn.1000-9604.2020.06.12","article-title":"Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study","volume":"32","author":"Lei","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/mabs.2.2.11221","article-title":"Catumaxomab: Clinical development and future directions","volume":"2","author":"Linke","year":"2010","journal-title":"MAbs"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.humpath.2003.08.026","article-title":"Frequent EpCam protein expression in human carcinomas","volume":"35","author":"Went","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_139","first-page":"2019","article-title":"Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash","volume":"18","author":"Carneiro","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.bjc.6603881","article-title":"Characterisation of the new EpCAM-specific antibody HO-3: Implications for trifunctional antibody immunotherapy of cancer","volume":"97","author":"Ruf","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","article-title":"The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II\/III trial","volume":"127","author":"Heiss","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41416-018-0150-6","article-title":"Randomised phase II trial to investigate catumaxomab (anti-EpCAM\u2009\u00d7\u2009anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer","volume":"119","author":"Kunzmann","year":"2018","journal-title":"Br. J. Cancer"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/6\/1376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:27:44Z","timestamp":1760138864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/6\/1376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":142,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["biomedicines10061376"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10061376","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}